Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:32 PM
Ignite Modification Date:
2025-12-24 @ 6:32 PM
NCT ID:
NCT00982657
Eligibility Criteria:
Inclusion Criteria:
* Histologically or cytologically confirmed advanced/metastatic solid tumor
* Having received at least 1 prior systemic therapy for the treatment of advanced/metastatic solid tumors
* Histologically or cytologically confirmed renal cell carcinoma with clear cell histology and evidence of metastasis (No previous systemic therapy for the treatment of metastatic renal cell carcinoma)
* Adequate laboratory tests
* Eastern Cooperative Oncology Group (ECOG) 0-1, Life expectancy \> or = 12 weeks and age \> or = 18 years
Exclusion Criteria:
* Patients intolerant of prior anti-angiogenic agents
* Recent history of bleeding or bleeding disorders
* History of tumors in the brain
* History of heart problems
* History of severe allergic reaction to antibody therapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00982657
Study Brief:
Protocol Section:
NCT00982657